Chemed Corporation

NYSE:CHE

Medical - Care Facilities

Healthcare
$546.72 +1.13%

+$4.91 today

Market cap
$7.12B
Beta
0.54
P/E (TTM)
23.2
EPS (TTM)
$19.00
Dividend yield
0.54%
52W Low $365.21High $562.77

Volume 0.17M

Average 0.25M

CHE Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Chemed CorporationNYSE: CHE

Gross Margin · Q2 FY2026 · quarter ended Jun 2026

Gross margin widens to 30.4%

Gross margin was 30.4% in Q2 FY2026, up 0.5 pp from a year earlier. On a trailing-twelve-month basis it was 30.4%, down 3.2 pp year over year. Over 3 fiscal years it narrowed by 5.9 pp.

Context

  • Gross margin widened in 0 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
30.4%+0.1 pp QoQ
Last fiscal yearDec 2025
30.0%-5.2 pp YoY
LTMJun 2026
30.4%-3.2 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+0.5 pp——
1 year-5.2 pp——
3 years-5.9 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
30.0%
Year-over-year change
-5.2pp

Gross Margin vs competitors

How CHE compares with its peers on the latest reported figures

  • CHE's LTM Jun 2026 gross margin of 30.4% is the 3rd highest of the 5 companies compared; the peer median is 25.3%.
  • Its year-over-year change of -3.2 pp is the lowest of 5, against a peer median of -0.1 pp.
  • Over three fiscal years its change of -5.9 pp compares with a peer median of +0.7 pp.
CHE Competitors Peer median
Gross Margin for CHE and competitors
Company Period LTM level YoY 3-year change
ADUSAddus HomeCare CorporationLTM Jun 202632.4% -0.2 pp+1.0 pp
AVAHAveanna Healthcare Holdings Inc.LTM Oct 202632.1% -1.4 pp+2.1 pp
CHEChemed CorporationLTM Jun 202630.4% -3.2 pp-5.9 pp
OPCHOption Care Health, Inc.LTM Sep 202618.5% -0.1 pp-3.9 pp
PNTGThe Pennant Group, Inc.LTM Mar 202614.8% +1.1 pp+0.5 pp
Peer median (excluding CHE) 25.3%-0.1 pp+0.7 pp

Competitors are the stored peer set for CHE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.14B2.13B2.26B2.43B2.53B
Cost of Revenue1.37B1.37B1.47B1.58B1.77B
Gross Profit769.8M765.09M798.82M854.35M758.34M
Gross Margin36.0%35.8%35.3%35.1%30.0%
Research & Development00000
Selling, General & Admin366.73M358.73M395.12M424.36M417.19M
Operating Expenses426.77M421.59M458.25M487.86M417.19M
Depreciation & Amortization59.05M59.17M60.87M63.05M64.84M
EBITDA411.23M393.44M414.34M464.29M422.37M
EBITDA Margin19.2%18.4%18.3%19.1%16.7%
Operating Income343.04M343.5M340.57M366.49M338.25M
Operating Margin16.0%16.1%15.0%15.1%13.4%
Interest Income377K355K6.27M14.61M8.75M
Interest Expense1.87M4.58M3.11M1.78M1.75M
Other Income / Expenses7.28M(13.82M)9.8M32.97M17.53M
Income Before Tax350.31M329.68M350.37M399.47M355.78M
Pre-Tax Margin16.4%15.4%15.5%16.4%14.1%
Income Tax Expense81.76M80.06M77.86M97.47M90.54M
Net Income268.55M249.62M272.51M302M265.24M
Net Margin12.6%11.7%12.0%12.4%10.5%
EPS (Basic)17.1416.7218.1120.1018.42
EPS (Diluted)16.8516.5317.9319.8918.42
Weighted Avg Shares15.67M14.93M15.05M15.02M14.4M
Weighted Avg Shares (Diluted)15.94M15.1M15.2M15.19M14.4M

Chemed Corporation

NYSE:CHE

Intrinsic Alpha fair value

Locked

Current Price

$546.72

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.